May 20, 2011
Allergan Inc. and two Japanese pharmaceutical companies sued Lupin Ltd. in Delaware on Wednesday to stop the company's proposed generic version of pinkeye treatment Zymar, following a similar suit to halt the manufacture of a stronger dosage.